肆客足球

Immunology Research Group
Welcome to Stellenbosch 肆客足球

Stellenbosch 肆客足球 Immunology Research Group

Publications

2017

  1. Luies L, Reenen MV, Ronacher K, Walzl G, Loots DT. Biomark Med. 2017 Dec;11(12):1057-1067. doi: 10.2217/bmm-2017-0133. Epub 2017 Nov 27.

  2. Thompson EG, Du Y, Malherbe ST, Shankar S, Braun J, Valvo J, Ronacher K, Tromp G, Tabb DL, Alland D, Shenai S, Via LE, Warwick J, Aderem A, Scriba TJ, Winter J, Walzl G, Zak DE9; Catalysis TB–Biomarker Consortium. Tuberculosis (Edinb). 2017 Dec;107:48-58. doi: 10.1016/j.tube.2017.08.004. Epub 2017 Aug 12.

  3. Nemes E, Hesseling AC, Tameris M, Mauff K, Downing K, Mulenga H, Rose P, van der Zalm M, Mbaba S, Van As D, Hanekom WA, Walzl G, Scriba TJ, McShane H, Hatherill M; MVA029 Study Team. Clin Infect Dis. 2017 Sep 26. doi: 10.1093/cid/cix834.

  4. Namuganga AR, Chegou NN, Mubiri P, Walzl G, Mayanja-Kizza H. BMC Infect Dis. 2017 Aug 31;17(1):600. doi: 10.1186/s12879-017-2687-z.

  5. Nemes E, Rozot V, Geldenhuys H, Bilek N, Mabwe S, Abrahams D, Makhethe L, Erasmus M, Keyser A, Toefy A, Cloete Y, Ratangee F, Blauenfeldt T, Ruhwald M, Walzl G, Smith B, Loxton AG, Hanekom WA, Andrews JR, Lempicki MD, Ellis R, Ginsberg AM, Hatherill M, Scriba TJ; C-040-404 Study Team and the Adolescent Cohort Study Team. Am J Respir Crit Care Med. 2017 Sep 1;196(5):638-648. doi: 10.1164/rccm.201704-0817OC.

  6. Changes in Host Immune-Endocrine Relationships during Tuberculosis Treatment in Patients with Cured and Failed Treatment Outcomes.

    Kleynhans L, Ruzive S, Ehlers L, Thiart L, Chegou NN, Conradie M, Kriel M, Stanley K, van der Spuy GD, Kidd M, van Helden PD, Walzl G, Ronacher K. Front Immunol. 2017 Jun 15;8:690. doi: 10.3389/fimmu.2017.00690. eCollection 2017.

  7. Awoniyi DO, Baumann R, Chegou NN, Kriel B, Jacobs R, Kidd M, Loxton AG, Kaempfer S, Singh M, Walzl G. Oncotarget. 2017 Jun 6;8(23):37525-37537. doi: 10.18632/oncotarget.16401.

  8. Malherbe ST, Shenai S, Ronacher K, Loxton AG, Dolganov G, Kriel M, Van T, Chen RY, Warwick J, Via LE, Song T, Lee M, Schoolnik G, Tromp G, Alland D, Barry CE 3rd, Winter J, Walzl G; Catalysis TB–Biomarker Consortium. Nat Med. 2017 Apr 7;23(4):526. doi: 10.1038/nm0417-526a.

  9. B-cells with a FasL expressing regulatory phenotype are induced following successful anti-tuberculosis treatment.

    van Rensburg IC, Kleynhans L, Keyser A, Walzl G, Loxton AG. Immun Inflamm Dis. 2016 Dec 27;5(1):57-67. doi: 10.1002/iid3.140. eCollection 2017 Mar.

  10. Van der Zalm MM, van Soelen N, Mandalakas AM, Jacobsen M, Detjen AK, Marx FM, Grewal HM, Cotton MF, WalzlG, Hesseling AC. Pediatr Infect Dis J. 2017 Feb;36(2):241-242. doi: 10.1097/INF.0000000000001408.

  11. Strijdom H, De Boever P, Walzl G, Essop MF, Nawrot TS, Webster I, Westcott C, Mashele N, Everson F, Malherbe ST, Stanley K, Kessler HH, Stelzl E, Goswami N. BMC Infect Dis. 2017 Jan 7;17(1):41. doi: 10.1186/s12879-016-2158-y.

  12. Safety and Immunogenicity of the Recombinant Mycobacterium bovis BCG Vaccine VPM1002 in HIV-Unexposed Newborn Infants in South Africa.

    Loxton AG, Knaul JK, Grode L, Gutschmidt A, Meller C, Eisele B, Johnstone H, van der Spuy G, Maertzdorf J, Kaufmann SH, Hesseling AC, Walzl G, Cotton MF; VPM Study Group. Clin Vaccine Immunol. 2017 Feb 6;24(2). pii: e00439-16. doi: 10.1128/CVI.00439-16.

  13. Mendes KR, Malone ML, Ndungu JM, Suponitsky-Kroyter I, Cavett VJ, McEnaney PJ, MacConnell AB, Doran TM, Ronacher K, Stanley K, Utset O, Walzl G, Paegel BM, Kodadek T. ACS Chem Biol. 2017 Jan 20;12(1):234-243. doi: 10.1021/acschembio.6b00855. Epub 2016 Dec 13.